Qube Research & Technologies (QRT)
LUMO

Qube Research & Technologies (QRT)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3
Closed -$7 – 4313
2024
Q2 		$7 Hold
3
– – ﹤0.01% 3637
2024
Q1 		$8 Hold
3
– – ﹤0.01% 4311
2023
Q4 		$9 Hold
3
– – ﹤0.01% 4177
2023
Q3 		$10 Buy
+3
New +$9 ﹤0.01% 3927
2021
Q1 		– Sell
-16,454
Closed -$588K – 2510
2020
Q4 		$588K Sell
16,454
-2,387
-13% -$41.2K 0.01% 1056
2020
Q3 		$260K Buy
+18,841
New +$282K ﹤0.01% 1297

Other funds holding LUMO

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LUMO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 3 shares — an estimated $7 sold.

Qube Research & Technologies (QRT) first reported a position in LUMO in Q3 2020 and held it in 6 quarters. The position peaked at $588K in Q4 2020. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $7.
  • Qube Research & Technologies (QRT) first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Lumos Pharma, Inc. Common Stock position peaked at $588K in Q4 2020.
  • 28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.